Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei-Chee Tai

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|April 24, 2021
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic CancerRachel L Dittmar, Suyu Liu, Mei Chee Tai, et al.
International Journal of Molecular Sciences|February 24, 2024
Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung AdenocarcinomaMei-Chee Tai, Leonidas E Bantis, Gargy Parhy, et al.
Nature Cell Biology|December 1, 2025
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancerWarapen Treekitkarnmongkol, Hiroshi Katayama, Deivendran Sankaran, et al.
International Journal of Molecular Sciences|August 26, 2022
A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune ResponseEhsan Irajizad, Johannes F Fahrmann, James P Long, et al.
Journal of Cellular and Molecular Medicine|September 9, 2020
CERS6 required for cell migration and metastasis in lung cancerMotoshi Suzuki, Ke Cao, Seiichi Kato, et al.
The Journal of Clinical Investigation|December 10, 2015
Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cellsMotoshi Suzuki, Ke Cao, Seiichi Kato, et al.
NPJ Breast Cancer|September 30, 2025
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriersMei-Chee Tai, Joe Dennis, Sue K Park, et al.
The Lancet Regional Health. Western Pacific|February 9, 2024
Age-specific breast and ovarian cancer risks associated with germline <i>BRCA1</i> or <i>BRCA2</i> pathogenic variants - an Asian study of 572 familiesWeang-Kee Ho, Nur Tiara Hassan, Sook-Yee Yoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2022
Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast CancerBoon Hong Ang, Weang Kee Ho, Eldarina Wijaya, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Association of <i>ESR1</i> germline variants with <i>TP53</i> somatic variants in breast tumors in a genome-wide studyNijole P Tjader, Abigail J Beer, Johnny Ramroop, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Prevention Research (Philadelphia, Pa.)|April 24, 2021
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic CancerRachel L Dittmar, Suyu Liu, Mei Chee Tai, et al.
International Journal of Molecular Sciences|February 24, 2024
Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung AdenocarcinomaMei-Chee Tai, Leonidas E Bantis, Gargy Parhy, et al.
Nature Cell Biology|December 1, 2025
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancerWarapen Treekitkarnmongkol, Hiroshi Katayama, Deivendran Sankaran, et al.
International Journal of Molecular Sciences|August 26, 2022
A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune ResponseEhsan Irajizad, Johannes F Fahrmann, James P Long, et al.
Journal of Cellular and Molecular Medicine|September 9, 2020
CERS6 required for cell migration and metastasis in lung cancerMotoshi Suzuki, Ke Cao, Seiichi Kato, et al.
The Journal of Clinical Investigation|December 10, 2015
Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cellsMotoshi Suzuki, Ke Cao, Seiichi Kato, et al.
NPJ Breast Cancer|September 30, 2025
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriersMei-Chee Tai, Joe Dennis, Sue K Park, et al.
The Lancet Regional Health. Western Pacific|February 9, 2024
Age-specific breast and ovarian cancer risks associated with germline <i>BRCA1</i> or <i>BRCA2</i> pathogenic variants - an Asian study of 572 familiesWeang-Kee Ho, Nur Tiara Hassan, Sook-Yee Yoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2022
Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast CancerBoon Hong Ang, Weang Kee Ho, Eldarina Wijaya, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Association of <i>ESR1</i> germline variants with <i>TP53</i> somatic variants in breast tumors in a genome-wide studyNijole P Tjader, Abigail J Beer, Johnny Ramroop, et al.
Pageof 3